Phase I Pharmacokinetic Study of RX0041-2

NCT02667106 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pharmaceutical Project Solutions, Inc.